Other ways to search: Events Calendar | UTHSC

Arijit Ganguli-Pharmacy Invited Speaker-Thursday

|

August Networking Lunch

University of Tennessee College of Pharmacy

Topic: Health Economics and Outcomes Research and Its Role in Pharma

 

Arijit Ganguli, PhD, MBA

Global Executive Director

& Global Head of Oncology Health Economics & Outcomes Research

Astellas Pharma

Thursday, August 22, 2024

12 P.M.-1 P.M. Central Time (Please bring your own lunch)

UTHSC College of Pharmacy Building

881 Madison Avenue, Room 683

Memphis, TN 38163

Zoom: https://tennesseehipaa.zoom.us/j/88061037552
Meeting ID: 880 6103 7552

One tap mobile
+13017158592,,88061037552# US (Washington DC) 13052241968,,88061037552#
+US

Speaker information:

Dr. Arijit Ganguli is a seasoned healthcare executive with over 20 years of experience in Health Economics and Outcomes Research (HEOR), specializing in oncology and immunology. Currently serving as the Global Executive Director and Global Head of Oncology HEOR at Astellas Pharma, Dr. Ganguli has successfully built and led high-performing teams, driving key global reimbursement milestones and product launches. With deep expertise in developing and executing Global reimbursement strategies, real-world evidence (RWE) plans, and patient-reported outcomes (PRO) initiatives, Dr. Ganguli has significantly contributed to the successful scientific evidence generation initiatives and market access of leading oncology therapies.

Dr. Ganguli holds a Doctor of Philosophy (PhD) in Health Outcomes and Policy Research from the University of Tennessee Health Science Center, a Master’s in Business Administration (MBA) with a focus on Marketing and a Bachelor of Pharmacy (BS. Pharmacy) degrees. Additionally, he completed Executive Education in Principles of Strategic Marketing at the Kellogg School of Management. A respected thought leader, Dr. Ganguli has authored over 100 peer-reviewed publications and is an active member of several professional organizations, including the American Society of Clinical Oncology and the International Society of Pharmacoeconomics and Outcomes Research.